In addition, COVID-19 promotes an imbalanced activation of the renin–angiotensin–aldosterone system (RAAS), which induces the downregulation of the membrane-bound ACE2 receptor that promotes the accumulation of angiotensin II by lowering its degradation into angiotensin 1–7. The gene discussed is AGT; the disease is COVID-19.